Remote Noninvasive Detection of Carbohydrate Metabolism Disorders by First-Lead ECG Screening in CardioQVARK Project

The main results of an experimental study on the approbation of the method of remote noninvasive detection by electrocardiogram on the first lead the carbohydrate metabolism disorders (CMD) using a portable electrocardiograph CardioQVARK and expert system ES diabetes mellitus (DM) are presented. The possibility of detecting cardio indication of (CMD) with sensitivity of 70% and specificity of more than 86% was confirmed. The possibility of remote non-invasive screening of the population with high sensitivity and specificity was confirmed by this method.